Biogen Sells Samsung Bioepis Stake In $2.3bn Buyout

Samsung Biologics To Take Full Ownership Of Biosimilars Joint Venture

Jan 28 2022

Samsung Biologics has taken control of the biosimilars joint venture • Source: Dennis Diatel / Alamy Stock Photo